{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:36:25Z","timestamp":1790811385211,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omtm.2020.05.021","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T21:49:28Z","timestamp":1590097768000},"page":"84-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Systemic Delivery of AAV-Fdxr Mitigates the Phenotypes of Mitochondrial Disorders in Fdxr Mutant Mice"],"prefix":"10.1016","volume":"18","author":[{"given":"Li","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Slone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Queme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taosheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.05.021_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0960-0760(92)90307-5","article-title":"Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis","volume":"43","author":"Hanukoglu","year":"1992","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.omtm.2020.05.021_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbamcr.2011.11.002","article-title":"Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis","volume":"1823","author":"Shi","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2020.05.021_bib3","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.85.19.7104","article-title":"Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen----q25 are expressed in steroidogenic tissues","volume":"85","author":"Solish","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.05.021_bib4","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1093\/hmg\/ddx377","article-title":"Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy","volume":"26","author":"Peng","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.05.021_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ajhg.2017.09.007","article-title":"FDXR Mutations Cause Sensorial Neuropathies and Expand the Spectrum of Mitochondrial Fe-S-Synthesis Diseases","volume":"101","author":"Paul","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.05.021_bib6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s10038-018-0515-y","article-title":"Biallelic mutations in FDXR cause neurodegeneration associated with inflammation","volume":"63","author":"Slone","year":"2018","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtm.2020.05.021_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jgg.2017.11.008","article-title":"The current landscape for the treatment of mitochondrial disorders","volume":"45","author":"Slone","year":"2018","journal-title":"J.\u00a0Genet. Genomics"},{"key":"10.1016\/j.omtm.2020.05.021_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11940-009-0046-0","article-title":"A modern approach to the treatment of mitochondrial disease","volume":"11","author":"Parikh","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.omtm.2020.05.021_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11940-014-0292-7","article-title":"Treatment of mitochondrial disorders","volume":"16","author":"Avula","year":"2014","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.omtm.2020.05.021_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated Virus (AAV) as a Vector for Gene Therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtm.2020.05.021_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrd.2018.110","article-title":"Gene therapy for neurological disorders: progress and prospects","volume":"17","author":"Deverman","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2020.05.021_bib12","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.ymthe.2017.08.004","article-title":"AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy","volume":"25","author":"Morabito","year":"2017","journal-title":"Mol. Ther"},{"key":"10.1016\/j.omtm.2020.05.021_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2020.05.021_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0167-4781(95)00172-D","article-title":"cDNA cloning of mouse ferredoxin reductase from kidney","volume":"1264","author":"Itoh","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2020.05.021_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1101\/gad.299388.117","article-title":"Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2","volume":"31","author":"Zhang","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2020.05.021_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajmg.1426","article-title":"Epidemiology and treatment of mitochondrial disorders","volume":"106","author":"Chinnery","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtm.2020.05.021_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1196\/annals.1293.023","article-title":"Mitochondrial encephalomyopathies: therapeutic approach","volume":"1011","author":"Dimauro","year":"2004","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.omtm.2020.05.021_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/mus.20598","article-title":"Approaches to the treatment of mitochondrial diseases","volume":"34","author":"DiMauro","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2020.05.021_bib19","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.addr.2008.05.001","article-title":"The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies","volume":"60","author":"Tarnopolsky","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"D1","key":"10.1016\/j.omtm.2020.05.021_bib20","doi-asserted-by":"crossref","first-page":"D1251","DOI":"10.1093\/nar\/gkv1003","article-title":"MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins","volume":"44","author":"Calvo","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2020.05.021_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10545-015-9831-y","article-title":"Spectrum of combined respiratory chain defects","volume":"38","author":"Mayr","year":"2015","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.05.021_bib22","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.05.021_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2020.05.021_bib24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/pan.12158","article-title":"Anesthetic considerations in patients with mitochondrial defects","volume":"23","author":"Niezgoda","year":"2013","journal-title":"Paediatr. Anaesth."},{"key":"10.1016\/j.omtm.2020.05.021_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/hum.2018.217","article-title":"Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy","volume":"30","author":"Cabrera-P\u00e9rez","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.021_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/hum.2018.020","article-title":"AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome","volume":"30","author":"Suzuki-Hatano","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.021_bib27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/gt.2017.53","article-title":"AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome","volume":"24","author":"Di Meo","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.021_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.crvi.2013.11.011","article-title":"Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial","volume":"337","author":"Cwerman-Thibault","year":"2014","journal-title":"C.\u00a0R. Biol."},{"key":"10.1016\/j.omtm.2020.05.021_bib29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/mt.2014.6","article-title":"Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE","volume":"22","author":"Torres-Torronteras","year":"2014","journal-title":"Mol. Ther"},{"key":"10.1016\/j.omtm.2020.05.021_bib30","first-page":"e52037","article-title":"Intravenous injections in neonatal mice","volume":"11","author":"Gombash Lampe","year":"2014","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtm.2020.05.021_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2020.05.021_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1744-9081-7-41","article-title":"Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug","volume":"7","author":"Vorhees","year":"2011","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.omtm.2020.05.021_bib33","first-page":"969","article-title":"Phenotypic and functional characterization of Bst+\/- mouse retina","volume":"8","author":"Riazifar","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2020.05.021_bib34","doi-asserted-by":"crossref","first-page":"e1005097","DOI":"10.1371\/journal.pgen.1005097","article-title":"Mutations of human NARS2, encoding the mitochondrial asparaginyl-tRNA synthetase, cause nonsyndromic deafness and Leigh syndrome","volume":"11","author":"Simon","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2020.05.021_bib35","first-page":"1","article-title":"Purification of a crude mitochondrial fraction by density-gradient centrifugation","volume":"4","author":"Graham","year":"2001","journal-title":"Curr. Protoc. Cell Biol"},{"key":"10.1016\/j.omtm.2020.05.021_bib36","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/hmg\/ddx262","article-title":"Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice","volume":"26","author":"Li","year":"2017","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012030108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012030108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:27:36Z","timestamp":1762421256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012030108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":36,"alternative-id":["S232905012030108X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.05.021","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Delivery of AAV-Fdxr Mitigates the Phenotypes of Mitochondrial Disorders in Fdxr Mutant Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}